Suppr超能文献

关于 C 肽在糖尿病和骨质疏松症中的潜在作用的最新研究进展。

An update on the potential role of C-peptide in diabetes and osteoporosis.

机构信息

Clinical Nutrition Unit, Department of Medical and Surgical Science, University Magna Graecia, Catanzaro, 88100, Italy.

Internal and Emergency Medicine and Center for Applied Clinical Research (Ce.R.C.A.) Clinical Institute "Beato Matteo", Vigevano, 27029, Italy.

出版信息

Endocrine. 2017 Dec;58(3):408-412. doi: 10.1007/s12020-017-1286-5. Epub 2017 Apr 3.

Abstract

PURPOSE

C-peptide secretion is deficient or absent in type 1 diabetes mellitus. It is well accepted that insulin replacement therapy cannot prevent the development of long-term diabetes-related complications, which can often be disabling or even life-threatening. Several cross-sectional investigations have suggested that residual C-peptide production in patients with type 1 diabetes mellitus would help prevent a number of complications. In animal models of diabetes and in patients with type 1 diabetes mellitus, C-peptide replacement improves renal function, skin and skeletal muscle blood flow, nerve conduction, glucose utilization, and other diabetes-related complications. Recent investigations suggest a new beneficial effect of C-peptide, which to date has never been studied. It is known that osteoporosis is the most prevalent short-term complication in type 1 diabetes mellitus. This review will highlight new insights into the pathophysiology and future therapeutic modalities for osteoporosis in individuals with diabetes.

METHODS

This review provides a concise summary of old and new insights into the role of C-peptide in diabetes-related complications.

RESULTS

The data suggest that C-peptide is a bioactive peptide, acting independently of insulin, which binds to a G-protein-coupled membrane binding site in different cell types. By triggering Ca-dependent intracellular signaling pathways, both Na, K-ATPase and endothelial nitric oxide synthase are activated. C-peptide may act on osteoblast cells by ERK 1/2 pathway activation, modulate collagen biosynthesis and RANKL expression. Furthermore, C-peptide-deficient postmenopausal women, not affected by diabetes, have a lower bone mineral density than those with normal C-peptide levels.

CONCLUSION

Taken together these studies encourage further investigations to elucidate the role of C-peptide in preventing bone loss in type 1 diabetes mellitus and in those individuals with C-peptide deficiency and osteoporosis.

摘要

目的

1 型糖尿病患者的 C 肽分泌不足或缺失。人们普遍认为,胰岛素替代疗法并不能预防长期糖尿病相关并发症的发生,这些并发症往往会导致残疾甚至危及生命。几项横断面研究表明,1 型糖尿病患者的残余 C 肽产生有助于预防多种并发症。在糖尿病动物模型和 1 型糖尿病患者中,C 肽替代可改善肾功能、皮肤和骨骼肌血流、神经传导、葡萄糖利用和其他糖尿病相关并发症。最近的研究表明 C 肽具有新的有益作用,迄今为止尚未对此进行研究。众所周知,骨质疏松症是 1 型糖尿病最常见的短期并发症。这篇综述将重点介绍有关糖尿病个体骨质疏松症的病理生理学和未来治疗方式的新见解。

方法

本综述简要总结了 C 肽在糖尿病相关并发症中的作用的旧有和新见解。

结果

数据表明,C 肽是一种生物活性肽,独立于胰岛素作用,它与不同细胞类型中的 G 蛋白偶联膜结合位点结合。通过触发 Ca 依赖性细胞内信号通路,Na+、K+-ATP 酶和内皮型一氧化氮合酶都被激活。C 肽可能通过 ERK1/2 通路的激活作用于成骨细胞,调节胶原蛋白生物合成和 RANKL 表达。此外,未受糖尿病影响的 C 肽缺乏绝经后妇女的骨矿物质密度低于 C 肽水平正常的妇女。

结论

综上所述,这些研究鼓励进一步研究阐明 C 肽在预防 1 型糖尿病和 C 肽缺乏及骨质疏松症个体骨丢失中的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验